Daniel Aghion serves as Executive at ORAMED PHARMACEUTICALS INC., where they oversee executive responsibilities. Since joining the company, Daniel Aghion has executed 3 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jan 30, 2024 involved receiving (via award) 3,750 shares valued at $0.
Daniel Aghion currently holds 38,820 shares of ORAMED PHARMACEUTICALS INC. (ORMP), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Daniel Aghion has been a net neutral trader of ORMP stock. They have purchased $0 and sold $0 worth of shares.
Daniel Aghion's most recent insider trade was on Jan 30, 2024, when they sold 3,750 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Jan 4, 2024 | ORMP | $0 | Award | 30,000 | $N/A | Discretionary |